Pharmaceutical combination and use thereof

Abstract

The present disclosure provides a pharmaceutical combination and use thereof. By using an effective amount of methyl-β-cyclodextrin as a preparation component or a combined auxiliary drug, the efficacy of ADC can be significantly improved, so that some of the ADC drugs with safety issues caused by excessive dosage can be developed. Moreover, due to the reduction in the dosage of ADC drugs, the cost of production and the cost of treatment for patients have also been greatly reduced, thereby being beneficial.

Dependencies are inferred from the claim text.